Vermillion, Inc. (NASDAQ:VRML)’s stock price passed above its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of $0.73 and traded as high as $0.77. Vermillion shares last traded at $0.72, with a volume of 12,470 shares trading hands.
The company has a debt-to-equity ratio of 0.10, a current ratio of 4.54 and a quick ratio of 4.53. The stock’s 50-day simple moving average is $0.67 and its 200 day simple moving average is $0.73.
Vermillion (NASDAQ:VRML) last posted its quarterly earnings data on Tuesday, November 12th. The company reported ($0.04) earnings per share for the quarter. Vermillion had a negative return on equity of 163.08% and a negative net margin of 353.32%. The firm had revenue of $1.29 million for the quarter.
About Vermillion (NASDAQ:VRML)
Vermillion, Inc, together with its subsidiaries, discovers, develops, and commercializes diagnostic and bio-analytical solutions that help physicians to diagnose, treat, and enhance gynecologic health outcomes for women primarily in the United States. The company's diagnostic tests include OVA1, a blood test for the pre-surgical identification of women who are at high risk of having a malignant ovarian tumor; and Overa, a multivariate index assay second generation test to determine the malignancy of ovarian cancer in women.
Featured Article: Trading based on a resistance level
Receive News & Ratings for Vermillion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vermillion and related companies with MarketBeat.com's FREE daily email newsletter.